Cytosorbents Corporation - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
CTSO Nasdaq 3841 www.cytosorbents.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cytosorbents Corporation

Cytosorbents Corporation (NASDAQ:CTSO): Is Breakeven Near? - Jul 2nd, 2025 6:44 am
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR - Jul 2nd, 2025 5:00 am
CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR - Jun 24th, 2025 5:00 am
CytoSorbents to Participate at the Jefferies Global Healthcare Conference - May 29th, 2025 5:00 am
CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025 - May 22nd, 2025 7:10 am
CTSO: CytoSorbents Reports Strong 1st Quarter 2025 Results - May 21st, 2025 3:24 am
CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and ... - May 15th, 2025 1:16 am
CytoSorbents: Q1 Earnings Snapshot - May 14th, 2025 2:50 pm
CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update - May 14th, 2025 2:01 pm
CTSO: CytoSorbents provides regulatory update for DrugSorb-ATR. - May 8th, 2025 8:04 am
CytoSorbents Provides Regulatory Update for DrugSorb-ATR - May 1st, 2025 2:15 pm
CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights - Apr 29th, 2025 5:00 am
CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program - Apr 21st, 2025 5:00 am
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller - Apr 17th, 2025 5:00 am
CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America - Apr 14th, 2025 5:00 am
CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants - Apr 4th, 2025 5:00 am
CTSO: CytoSorbents Reports 4th quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. - Apr 4th, 2025 3:16 am
CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Apr 1st, 2025 1:04 am
CytoSorbents: Q4 Earnings Snapshot - Mar 31st, 2025 2:59 pm
CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - Mar 31st, 2025 2:15 pm